Indegene Limited
Indegene Limited (INDGN.BO) Stock Competitors & Peer Comparison
See (INDGN.BO) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| INDGN.BO | ₹479.00 | +0.00% | 118.5B | 27.06 | ₹18.22 | +0.41% |
| IKS.NS | ₹1,456.10 | +0.00% | 240B | 36.83 | ₹38.90 | N/A |
| IKS.BO | ₹1,457.85 | +0.00% | 239.6B | 36.69 | ₹38.99 | N/A |
| SAGILITY.BO | ₹42.41 | +0.00% | 200.3B | 23.64 | ₹1.81 | +0.12% |
| SAGILITY.NS | ₹42.40 | +0.00% | 200.1B | 23.62 | ₹1.81 | +0.12% |
| INDGN.NS | ₹479.80 | +0.00% | 118.5B | 27.07 | ₹18.22 | +0.41% |
Stock Comparison
INDGN.BO vs IKS.NS Comparison February 2026
INDGN.BO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, INDGN.BO stands at 118.5B. In comparison, IKS.NS has a market cap of 240B. Regarding current trading prices, INDGN.BO is priced at ₹479.00, while IKS.NS trades at ₹1,456.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
INDGN.BO currently has a P/E ratio of 27.06, whereas IKS.NS's P/E ratio is 36.83. In terms of profitability, INDGN.BO's ROE is +0.17%, compared to IKS.NS's ROE of +0.37%. Regarding short-term risk, INDGN.BO is less volatile compared to IKS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for INDGN.BO.Check IKS.NS's competition here